4/10
08:05 am
BCRX
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
Low
Report
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
4/10
07:08 am
BCRX
Rating for BCRX
Low
Report
Rating for BCRX
4/10
07:08 am
BCRX
Rating for BCRX
Low
Report
Rating for BCRX